These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1876981)

  • 1. Regression of phenytoin-induced gingival overgrowth after withdrawal of medication.
    Dahllöf G; Axiö E; Modéer T
    Swed Dent J; 1991; 15(3):139-43. PubMed ID: 1876981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measured effect of phenytoin withdrawal on gingival hyperplasia in children.
    Brunsvold M; Tomasovic J; Ruemping D
    ASDC J Dent Child; 1985; 52(6):417-21. PubMed ID: 3864798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of phenytoin induced gingival overgrowth in epileptic children: a six month evaluation.
    Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P
    J Indian Soc Pedod Prev Dent; 2002 Jun; 20(2):73-80. PubMed ID: 12435021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin-induced gingival overgrowth control in severely retarded children.
    Steinberg SC; Steinberg AD
    J Periodontol; 1982 Jul; 53(7):429-33. PubMed ID: 6956708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a plaque control program on the development of phenytoin-induced gingival overgrowth. A 2-year longitudinal study.
    Dahllöf G; Modéer T
    J Clin Periodontol; 1986 Oct; 13(9):845-9. PubMed ID: 3465754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and saliva concentrations of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients.
    Ball DE; McLaughlin WS; Seymour RA; Kamali F
    J Periodontol; 1996 Jun; 67(6):597-602. PubMed ID: 8794970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of phenytoin-induced gingival overgrowth in non-institutionalized epileptic children subjected to different plaque control programs.
    Modéer T; Dahllöf G
    Acta Odontol Scand; 1987 Apr; 45(2):81-5. PubMed ID: 2955633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultrastructural study on phenytoin-induced gingival proliferation].
    Meng HX
    Zhonghua Yi Xue Za Zhi; 1988 Jan; 68(1):31-2, 3. PubMed ID: 3133090
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of sulfated glycosaminoglycans by human gingival fibroblasts from phenytoin-induced gingival overgrowth in vitro.
    Dahllöf G; Hjerpe A
    Scand J Dent Res; 1987 Jun; 95(3):250-5. PubMed ID: 3474765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients in general medical practice.
    Thomason JM; Seymour RA; Rawlins MD
    Community Dent Oral Epidemiol; 1992 Oct; 20(5):288-91. PubMed ID: 1424550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 5,5-diphenylhydantoin on a gingival hyperplasia development.
    Drízhal I; Spacek J; Hrdinová V; Lichý J; Kaut V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):625-89. PubMed ID: 6972082
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gingival hyperplasia in epileptic patients treated with diphenylhydantoin. Study by light and electron microscopy].
    Tsutsumi V; Hara Ortíz F; Alvarez Fuertes G
    Rev Invest Salud Publica; 1973; 33(3-4):1-16. PubMed ID: 4791088
    [No Abstract]   [Full Text] [Related]  

  • 13. Diphenylhydantoin-induced gingival overgrowth in man: a clinico-pathological study.
    Peñarrocha-Diago M; Bagán-Sebastián JV; Vera-Sempere F
    J Periodontol; 1990 Sep; 61(9):571-4. PubMed ID: 2213467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental root abnormalities and gingival overgrowth in epileptic patients receiving anticonvulsant therapy.
    Girgis SS; Staple PH; Miller WA; Sedransk N; Thompson T
    J Periodontol; 1980 Aug; 51(8):474-82. PubMed ID: 6931209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histopathology of gingival manifestations of hydantoin therapy].
    Hanzély B
    Fogorv Sz; 1976; 69 Suppl():418-20. PubMed ID: 1071997
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenytoin induced gingival overgrowth in institutionalized epileptics.
    Hassell T; O'Donnell J; Pearlman J; Tesini D; Murphy T; Best H
    J Clin Periodontol; 1984 Apr; 11(4):242-53. PubMed ID: 6584450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of phenytoin on cytoplasmic free Ca2+ level in human gingival fibroblasts.
    Modéer T; Brunius G; Mendez C; Juntti-Berggren L; Berggren PO
    Scand J Dent Res; 1991 Aug; 99(4):310-5. PubMed ID: 1771377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gingival hyperplasia resulting from diphenylhydantoin in children and adults.
    Matsumoto K; Nakagawa K; Kaneko Z
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):369-71. PubMed ID: 1176242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Images in clinical medicine. Gingival hyperplasia induced by phenytoin.
    Sharma S; Dasroy SK
    N Engl J Med; 2000 Feb; 342(5):325. PubMed ID: 10655531
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral health in non-institutionalized epileptic children with special reference to phenytoin medication.
    Modéer T; Dahllöf G; Theorell K
    Community Dent Oral Epidemiol; 1986 Jun; 14(3):165-8. PubMed ID: 3459615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.